Invention Grant
- Patent Title: Heterocyclic compounds as arginase inhibitors
-
Application No.: US16956693Application Date: 2018-12-21
-
Publication No.: US11655260B2Publication Date: 2023-05-23
- Inventor: Zhaoyin Wang , Nanxin Li , Jianbin Ma , Yanqiang Shao
- Applicant: Guangdong Newopp Biopharmaceuticals Co., Ltd.
- Applicant Address: CN Guangzhou
- Assignee: GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD.
- Current Assignee: GUANGDONG NEWOPP BIOPHARMACEUTICALS CO., LTD.
- Current Assignee Address: CN Guangzhou
- Agency: MaxGoLaw PLLC
- International Application: PCT/CN2018/122815 2018.12.21
- International Announcement: WO2019/120296A 2019.06.27
- Date entered country: 2020-06-22
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61K45/06
Abstract:
Heterocyclic compounds are provided as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceutical composition including the compound.
Public/Granted literature
- US20200325161A1 HETEROCYCLIC COMPOUNDS AS ARGINASE INHIBITORS Public/Granted day:2020-10-15
Information query
